Skip to main content
. Author manuscript; available in PMC: 2008 May 5.
Published in final edited form as: J Clin Oncol. 2004 Oct 13;22(22):4463–4473. doi: 10.1200/JCO.2004.11.035

Fig 4.

Fig 4

Antibody-dependent cell-mediated cytotoxicity using the LA-N-5 target with peripheral-blood mononuclear cells obtained from patients on day 1 (before treatment) and day 8. Mean lytic units (+ SE) for cultures containing medium alone, interleukin-2 (IL-2; 100 U/mL), or EMD 273063 (0.25 μg/mL). Significant differences are shown for day 8 versus day 1. (**), P < .01; (***), P < .001.